Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Haupt

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Oncogene|April 21, 2001
Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53I Fillippovich, N Sorokina, M Gatei, et al.
Oncogene|September 13, 2011
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancyM V Astle, K M Hannan, P Y Ng, et al.
Cell Death and Differentiation|March 28, 2009
E6AP promotes the degradation of the PML tumor suppressorI Louria-Hayon, O Alsheich-Bartok, Y Levav-Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2014
Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific deathS E Birch, J G Kench, E Takano, et al.
Oncogene|September 20, 2016
Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6APP J Paul, D Raghu, A-L Chan, et al.
Cell Death & Disease|July 17, 2015
Targeting Mdmx to treat breast cancers with wild-type p53S Haupt, D Buckley, J-M B Pang, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Oncogene|April 21, 2001
Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53I Fillippovich, N Sorokina, M Gatei, et al.
Oncogene|September 13, 2011
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancyM V Astle, K M Hannan, P Y Ng, et al.
Cell Death and Differentiation|March 28, 2009
E6AP promotes the degradation of the PML tumor suppressorI Louria-Hayon, O Alsheich-Bartok, Y Levav-Cohen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 19, 2014
Expression of E6AP and PML predicts for prostate cancer progression and cancer-specific deathS E Birch, J G Kench, E Takano, et al.
Oncogene|September 20, 2016
Restoration of tumor suppression in prostate cancer by targeting the E3 ligase E6APP J Paul, D Raghu, A-L Chan, et al.
Cell Death & Disease|July 17, 2015
Targeting Mdmx to treat breast cancers with wild-type p53S Haupt, D Buckley, J-M B Pang, et al.
Pageof 4